Refinery Ventures

Tim Schigel leads the firm as Managing Partner. The investment team is small, comprising a Principal, an Associate, and a Director of Operations under his direction. The precise governance structure for final investment committee approval has not been publicly detailed, though Schigel’s role as serial entrepreneur and prior venture investor at firms such as Allos Ventures positions him as the central decision-maker.

Refinery explicitly targets founders in 'emerging venture markets' — geographies where venture capital density is lower than coastal hubs. Its primary sourcing advantage comes from Schigel’s established network in the Midwest and the firm’s content strategy, particularly the Fast Frontiers podcast, which surfaces non-obvious companies. The firm also relies on referrals from its extended bench of serial entrepreneur-advisors.

Refinery does not describe itself as a generalist firm. It concentrates on early-scale technology companies in healthcare, human capital, media, and marketing. Within those verticals, it looks for teams with unique, contrarian insights into complex industry problems and a demonstrated ability to generate consistent revenue before scaling.

The firm invests in companies that have achieved product-market fit and are on a trajectory toward a Series A round. This 'early-scale' focus is distinct from seed-stage investing — Refinery looks for a consistent revenue stream and early customer validation before committing capital. It then supports the operational transition from founder-led sales to a repeatable go-to-market engine.

Publicly available sourcing, including the firm’s website, describes only direct investments into operating companies. There is no mention of fund-of-funds activity, limited-partner commitments to other GPs, or secondary-market purchases. The firm’s operational-playbook narrative strongly suggests a direct-deal-only approach.

Refinery does not publicly disclose its limited partners or the origin of its fund capital. The firm operates as an independent venture capital manager; there is no disclosed connection to a single-family office, pension fund, or corporate balance sheet. This opacity is common for emerging managers competing in lower-profile geographies.

The firm has not published a formal co-investment policy. Its promotional material, including testimonials, emphasizes its ability to introduce portfolio companies to larger institutional investors like Bain Capital — as it did for Halo Health. This suggests Refinery is open to syndicating deals with larger venture or growth-equity firms, acting as an early-stage feeder into top-tier investor networks.